Evidence map›Paper›PMID 28417961›Full record

ArticleScientific reports2017

High-Throughput Sequencing and Co-Expression Network Analysis of lncRNAs and mRNAs in Early Brain Injury Following Experimental Subarachnoid Haemorrhage.

Jianhua Peng, Yue Wu, Xiaocui Tian, Jinwei Pang, Li Kuai, Fang Cao, Xinghu Qin, Jianjun Zhong, Xinshen Li, Yong Li and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Jianhua PengDepartment of Neurosurgery, the Affiliated Hospital of Southwest Medical University, Luzhou, China.
Yue WuDepartment of Neurosurgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Xiaocui TianChongqing Key Laboratory of Biochemistry and Molecular Pharmacology, College of Pharmacy, Chongqing, China.
Jinwei PangDepartment of Neurosurgery, the Affiliated Hospital of Southwest Medical University, Luzhou, China.
Li KuaiDepartment of Ophthalmology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
Fang CaoDepartment of Neurovascular Disease, the Affiliated Hospital of Zunyi Medical College, Zunyi, China.
Xinghu QinDepartment of Neurosurgery, the Affiliated Hospital of Southwest Medical University, Luzhou, China.
Jianjun ZhongDepartment of Neurosurgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Xinshen LiDepartment of Neurosurgery, the Affiliated Hospital of Southwest Medical University, Luzhou, China.
Yong LiDepartment of Neurosurgery, the Affiliated Hospital of Southwest Medical University, Luzhou, China.
Xiaochuan SunDepartment of Neurosurgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Ligang ChenDepartment of Neurosurgery, the Affiliated Hospital of Southwest Medical University, Luzhou, China.
Yong JiangDepartment of Neurosurgery, the Affiliated Hospital of Southwest Medical University, Luzhou, China.
Affiliated Hospital of Southwest Medical University · CNFirst Affiliated Hospital of Chongqing Medical University · CNAffiliated Hospital of Zunyi Medical College · CNChongqing Medical and Pharmaceutical College · CNChongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Subarachnoid haemorrhage (SAH) is a fatal neurovascular disease following cerebral aneurysm rupture with high morbidity and mortality rates. Long non-coding RNAs (lncRNAs) are a type of mammalian genome transcript, are abundantly expressed in the brain and are involved in many nervous system diseases. However, little is currently known regarding the influence of lncRNAs in early brain injury (EBI) after SAH. This study analysed the expression profiles of lncRNAs and mRNAs in SAH brain tissues of mice using high-throughput sequencing. The results showed a remarkable difference in lncRNA and mRNA transcripts between SAH and control brains. Approximately 617 lncRNA transcripts and 441 mRNA transcripts were aberrantly expressed at 24 hours after SAH. Gene ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis indicated that the differentially expressed mRNAs were mostly involved in inflammation. Based on the lncRNA/mRNA co-expression network, knockdown of fantom3_F730004F19 reduced the mRNA and protein levels of CD14 and toll-like receptor 4 (TLR4) and attenuated inflammation in BV-2 microglia cells. These results indicate that lncRNA fantom3_F730004F19 may be associated with microglia induced inflammation via the TLR signaling pathway in EBI following SAH. LncRNA represent a potential therapeutic target for the prognosis, diagnosis, and treatment of SAH.

Indexed as

Gene Expression RegulationSignal TransductionAnimalsBrain InjuriesCell LineHigh-Throughput Nucleotide SequencingMiceNerve Tissue ProteinsRNA, Long NoncodingRNA, MessengerSubarachnoid HemorrhageNerve Tissue ProteinsRNA, Long NoncodingRNA, Messenger

Identifiers

PMID28417961
PMCPMC5394545
OpenAlexW2606991764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.